Enorama Pharma AB (publ) (ERMA.ST)
SEK 2.95
(3.15%)
SEK 2.95
(3.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.35 Million | 6.84 Million | 11.03 Million | 2.14 Million | 7.61 Million | 5.25 Million |
| Cost of Revenue | 5.25 Million | 7.46 Million | 8.9 Million | -219 Thousand | -2.82 Million | -6.72 Million |
| Gross Profit | -3.9 Million | -616 Thousand | 2.13 Million | 2.36 Million | 10.43 Million | 11.97 Million |
| Operating Expenses | 38.22 Million | 41.34 Million | 29.07 Million | 25.37 Million | 33.31 Million | 27.47 Million |
| Selling, General and Administrative Expenses | 35.35 Million | 37.82 Million | 17.85 Million | 16.3 Million | 25.13 Million | 21.49 Million |
| Research and Development Expenses | 2.87 Million | 2.87 Million | -1.76 Million | 393 Thousand | - | - |
| Other Expenses | - | 41.34 Million | 12.98 Million | 9.07 Million | 8.17 Million | 5.97 Million |
| Cost and Expenses | 43.48 Million | 48.81 Million | 37.97 Million | 25.15 Million | 30.48 Million | 20.74 Million |
| Operating Income | -41.83 Million | -41.47 Million | -26.94 Million | -23.01 Million | -22.87 Million | -15.49 Million |
| Interest Expense | 883 Thousand | 1.27 Million | 802 Thousand | 445 Thousand | 922.78 Thousand | 846.84 Thousand |
| Income Tax Expense | - | -250 Thousand | 802 Thousand | 445 Thousand | 922.78 Thousand | -153.67 Thousand |
| Earnings before Tax | -44.61 Million | -42.03 Million | -27.74 Million | -23.45 Million | -23.79 Million | -16.33 Million |
| Net Income | -44.61 Million | -41.78 Million | -28.54 Million | -23.9 Million | -24.72 Million | -16.33 Million |
| Earnings Per Share Basic | -1.61 | -4.40 | -3.80 | -3.54 | -3.69 | -3.08 |
| Earnings Per Share Diluted | -1.61 | -4.40 | -3.80 | -3.54 | -3.69 | -3.08 |
| Weighted Average Shares Outstanding | 27.69 Million | 9.48 Million | 7.51 Million | 6.74 Million | 6.7 Million | 5.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.69 Million | 9.48 Million | 7.51 Million | 6.74 Million | 6.7 Million | 5.29 Million |
| Gross Margin | -2.87 | -0.09 | 0.19 | 1.10 | 1.37 | 2.28 |
| EBIT Margin | -31.70 | -5.47 | -2.32 | -10.57 | -2.99 | -2.95 |
| Profit Margin | -32.85 | -6.10 | -2.59 | -11.14 | -3.25 | -3.11 |
| EBITDA | -43.05 Million | -37.22 Million | -26.27 Million | -22.68 Million | -22.72 Million | -15.48 Million |
| Earnings Before Tax Margin | -30.81 | -6.06 | -2.44 | -10.72 | -3.01 | -2.95 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.65 Million | -10 Thousand | 1.35 Million | 172 Thousand | 51 Thousand | 457 Thousand |
| Cost of Revenue | 12 Million | 10.02 Million | 40.32 Million | 11.41 Million | 1.04 Million | 342 Thousand |
| Gross Profit | -6.34 Million | -10.03 Million | -38.96 Million | -11.24 Million | -990 Thousand | 115 Thousand |
| Operating Expenses | 8.79 Million | 8.45 Million | 2.87 Million | 9.05 Million | 11.52 Million | 8.81 Million |
| Selling, General and Administrative Expenses | 7.95 Million | 7.6 Million | - | 8.55 Million | 10.19 Million | 7.98 Million |
| Research and Development Expenses | - | - | - | 718 Thousand | 718 Thousand | - |
| Other Expenses | 832 Thousand | - | - | - | - | - |
| Cost and Expenses | 12 Million | 10.02 Million | 43.19 Million | 11.41 Million | 12.56 Million | 9.15 Million |
| Operating Income | -6.34 Million | -10.03 Million | -41.83 Million | -11.24 Million | -12.51 Million | -8.69 Million |
| Interest Expense | 427 Thousand | 105 Thousand | 883 Thousand | -35 Thousand | 507 Thousand | 115 Thousand |
| Income Tax Expense | - | 814.72 Thousand | 509.1 Thousand | 833.18 Thousand | 31 Thousand | 982 Thousand |
| Earnings before Tax | -6.76 Million | -7.9 Million | -44.61 Million | -13.74 Million | -12.98 Million | -7.82 Million |
| Net Income | -6.76 Million | -7.9 Million | -44.61 Million | -13.74 Million | -12.98 Million | -7.82 Million |
| Earnings Per Share Basic | -0.14 | -0.19 | - | -0.29 | -0.32 | -0.25 |
| Earnings Per Share Diluted | -0.14 | -0.19 | - | -0.29 | -0.32 | -0.25 |
| Weighted Average Shares Outstanding | 48.53 Million | 42.66 Million | 33.58 Million | 48 Million | 40.3 Million | 31.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.53 Million | 42.66 Million | 33.58 Million | 48 Million | 40.3 Million | 31.35 Million |
| Gross Margin | -1.12 | 1003.00 | -28.69 | -65.37 | -19.41 | 0.25 |
| EBIT Margin | -0.97 | 917.20 | - | -60.27 | -227.22 | -14.93 |
| Profit Margin | -1.20 | 790.60 | -32.85 | -79.93 | -254.65 | -17.13 |
| EBITDA | -5.5 Million | -9.17 Million | - | -10.36 Million | -11.58 Million | -6.82 Million |
| Earnings Before Tax Margin | -1.12 | 1003.00 | -30.81 | -65.37 | -245.31 | -19.03 |
300748
2764
LOGL
TIGER
CHMBBRW
NSHS